Monitoring and Managing Cardiometabolic Risk in People on Antipsychotic Medications

Dates and Times

Start: 10/2/2024 1:00 PM
End: 10/2/2024 2:00 PM

Objectives

-Identify major cardiometabolic risk factors in people with psychotic disorders.
-Describe recommendations for cardiometabolic risk monitoring in people taking antipsychotic medication.
-Implement appropriate clinical interventions for people with heightened cardiometabolic risk and metabolic syndrome.

Speakers

Accreditation Statement

The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ^™. Physicians should only claim credit commensurate with the extent of their participation in the activity.